Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report-Reference-Cited by-同舟云学术

Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report

Published:2022-07 Issue: Volume:78 Page:17-26
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Viviani Laura^ORCID,Reid Kirsty,Gastineau Thierry,Milne Catherine,Smith Dean^ORCID,Levis Robin,Lei Dianliang,van Ooij Mark,Gilbert Philippe Alexandre,Vandeputte Joris,Xie Jianxun,Madhuri Leena,Shaid Shahjahan,Kubiak Vaughn^ORCID,Suri Rajinder,Mizukami Takuo,Shirasaki Yoshihisa,Li Xiantang,Zhou Ying-Ying,Trapkova Alla,Goel Sunil,Prakash Jai,Subagio Amrullah Aninditio,Suwarni Eniek,Jung Kyung Jin^ORCID,Sanyal Gautam^ORCID,Das Pradip,Coppens Emmanuelle^ORCID,Wright David,Peng Zhechu,Northeved Helle,Jungbäck Carmen,Kirpitchenok Tatiana,Del Pace Lorenzo,Seo Borami,Poojary Brinda^ORCID,Ottoni Antoniana

Funder

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference29 articles.

1. Global harmonization of vaccine testing requirements: making elimination of the ATT and TABST a concrete global achievement;Viviani;Biologicals,2020

2. Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities;Akkermans;Biologicals,2020

3. WHO expert committee on biological standardization, sixty-ninth report TRS 1016 https://apps.who.int/iris/bitstream/handle/10665/325184/9789241210256-eng.pdf?ua=1.

4. Removal of the innocuity test from the International Pharmacopoeia and WHO recommendations for vaccines and biological products;Lei;Biologicals,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine process technology—A decade of progress;Biotechnology and Bioengineering;2024-05-06

2. False positive findings associated with adenoviral vector-based vaccine underscore the regulatory necessity to eliminate abnormal toxicity test;Regulatory Toxicology and Pharmacology;2024-05

3. Expression system and purification process for the vaccine production;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

4. Global equity and timely access: COVID-19 & beyond 23rd DCVMN Annual General Meeting 2022 report;Vaccine: X;2023-12

5. Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of National Control Laboratories and National Regulatory Authorities;Biologicals;2023-11